Emepronium API Manufacturers

compare suppliers & get competitive offers

teaser-1024x654-1
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Emepronium is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Emepronium or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Emepronium API 27892-33-7?

Description:
Here you will find a list of producers, manufacturers and distributors of Emepronium. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Emepronium 
Synonyms:
 
Cas Number:
27892-33-7 
DrugBank number:
DB13505 
Unique Ingredient Identifier:
04QQ8SWA4U

General Description:

Emepronium is a chemical compound identified by the CAS number 27892-33-7. It is known for its distinct pharmacological properties and applications.

Classification:

Emepronium belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups, classified under the direct parent group Diphenylmethanes. This compound is a part of the Organic compounds, falling under the Benzenoids superclass, and categorized within the Benzene and substituted derivatives class, specifically within the Diphenylmethanes subclass.

Categories:

Emepronium is categorized under the following therapeutic classes: Agents producing tachycardia, Alimentary Tract and Metabolism, Amines, Anticholinergic Agents, Autonomic Agents, Central Nervous System Depressants, Cholinergic Agents, Drugs for Functional Gastrointestinal Disorders, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Genitourinary Agents, Hypnotics and Sedatives, Muscarinic Antagonists, Nervous System, Neurotransmitter Agents, Onium Compounds, Parasympatholytics, Peripheral Nervous System Agents, Psycholeptics, Quaternary Ammonium Compounds, Urological Agents, Urologicals. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Emepronium is a type of Antispasmodics


Antispasmodics are a category of pharmaceutical active pharmaceutical ingredients (APIs) commonly used to treat muscle spasms and cramps. They work by targeting and relaxing the smooth muscles found in various organs, including the gastrointestinal tract, urinary tract, and blood vessels.

These APIs exert their effects by inhibiting the excessive contraction of muscles, thereby relieving pain and discomfort associated with spasms. Antispasmodics can be further classified into two main types: antimuscarinics and calcium channel blockers.

Antimuscarinics, such as hyoscine butylbromide and dicyclomine, function by blocking the action of acetylcholine, a neurotransmitter that stimulates muscle contractions. By inhibiting the binding of acetylcholine to its receptors, antimuscarinics help relax the smooth muscles, particularly in the gastrointestinal tract, providing relief from conditions like irritable bowel syndrome and colic.

On the other hand, calcium channel blockers, including diltiazem and nifedipine, work by blocking the influx of calcium ions into muscle cells. This inhibition prevents the contractile proteins in the muscles from interacting, resulting in muscle relaxation. Calcium channel blockers find applications in the treatment of various conditions, including uterine spasms, coronary artery spasms, and hypertension.

Antispasmodics are available in different formulations, including tablets, capsules, and injections, allowing for flexible dosing options. They are typically prescribed by healthcare professionals and should be used under medical supervision to ensure appropriate dosage and minimize potential side effects.

In summary, antispasmodics are a vital category of pharmaceutical APIs that effectively alleviate muscle spasms and cramps. Their mechanism of action involves targeting either muscarinic receptors or calcium channels, depending on the specific type. These medications provide relief to patients suffering from various conditions involving excessive muscle contractions.